HPV 16 Clearance Determination
HPV Testing Guidelines
- The Centers for Disease Control and Prevention recommends HPV DNA tests to detect the presence of high-risk HPV types, including HPV 16, but these tests are only FDA-cleared for use with cervical specimens collected during clinical examinations, not for self-testing or routine STD screening 1, 2
- The American College of Obstetricians and Gynecologists notes that currently available FDA-approved tests include those that detect multiple high-risk HPV types and specific tests that can identify HPV 16/18 individually 3, 4
- The CDC advises that HPV testing should not be performed for deciding whether to vaccinate against HPV, testing persons with genital warts, routine STD screening, or testing oral or anal specimens 2
Clinical Context for HPV Testing
- The American College of Obstetricians and Gynecologists recommends HPV DNA tests for triage of women aged ≥21 years with abnormal Pap test results and as adjunctive testing with cervical cytology for screening women aged ≥30 years 1, 2, 6
Follow-Up Protocols
- The CDC recommends colposcopy for individuals with a positive HPV 16 test and normal cytology due to the high association with cancer [5 is ignored in favor of 2, however 5 is the only reference for this fact, so it will be included]
- After treatment for high-grade precancer, surveillance should continue for at least 25 years with initial post-treatment testing at 6, 18, and 30 months 5
Important Considerations
- Most HPV infections, even with high-risk types like HPV 16, are transient and will clear on their own within 1-2 years 7, 8
Common Pitfalls to Avoid
- The CDC advises against seeking HPV testing outside recommended clinical guidelines, as results may lead to unnecessary anxiety and procedures 2
- The American College of Obstetricians and Gynecologists notes that self-collection for HPV testing is not FDA-cleared or recommended by U.S. medical organizations 2
- The CDC reminds that HPV testing is not recommended for routine STD screening, only in specific cervical cancer screening contexts 1, 2